Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php on line 6114

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893

Warning: Cannot modify header information - headers already sent by (output started at /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php:6114) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/rest-api/class-wp-rest-server.php on line 1893
{"id":125018,"date":"2024-02-01T12:45:53","date_gmt":"2024-02-01T12:45:53","guid":{"rendered":"https:\/\/nursingassignmentcrackers.com\/?p=125018"},"modified":"2024-03-23T07:41:28","modified_gmt":"2024-03-23T07:41:28","slug":"nurs-6630-neurobiology-and-medication-adherence-concepts-new","status":"publish","type":"post","link":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/","title":{"rendered":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW"},"content":{"rendered":"

NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW<\/span><\/h2>\n

Sample Answer for NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW Included After Question<\/strong><\/h2>\n

NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS<\/span><\/a>\u00a0<\/span><\/h2>\n

RESOURCES<\/span>\u00a0<\/span><\/h3>\n
\"NURS
NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW<\/figcaption><\/figure>\n

Be sure to review the Learning Resources before completing this activity.<\/span>
\nClick the weekly resources link to access the resources.\u202f<\/span>\u00a0<\/span><\/p>\n

WEEKLY RESOURCES<\/span><\/b><\/a>\u00a0<\/span><\/h2>\n

BY DAY 7<\/span>\u00a0<\/span><\/h4>\n

Complete the 20-question self assessment to gauge your understanding of this module\u2019s content.<\/span>\u00a0<\/span><\/p>\n

Attempt History<\/span>\u00a0<\/span><\/p>\n\n\n\n\n
\u00a0<\/span><\/td>\nAttempt<\/span><\/b>\u00a0<\/span><\/td>\nTime<\/span><\/b>\u00a0<\/span><\/td>\nScore<\/span><\/b>\u00a0<\/span><\/td>\n<\/tr>\n
LATEST<\/span><\/b>\u00a0<\/span><\/td>\nAttempt 1<\/span><\/a>\u00a0<\/span><\/td>\n7 minutes<\/span>\u00a0<\/span><\/td>\n0 out of 0<\/span>\u00a0<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Score for this quiz:\u202f<\/span>0<\/span><\/b>\u202fout of 0<\/span>\u00a0<\/span><\/p>\n

Submitted Mar 17 at 5:36am<\/span>\u00a0<\/span><\/p>\n

This attempt took 7 minutes.<\/span>\u00a0<\/span><\/p>\n

\u202f<\/span><\/p>\n

A Sample Answer For the Assignment: NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW<\/strong><\/h2>\n

Title: NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW<\/strong><\/h2>\n

Question 1<\/span><\/b>\u00a0<\/span><\/h2>\n

0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

Introducing adherence in facilitating treatment goals is something that would be necessary in a patient who has previously displayed nonadherence patterns.<\/span>\u00a0<\/span><\/p>\n

You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

[Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

True<\/span>\u00a0<\/span><\/p>\n

\u202f<\/span>\u00a0<\/span><\/p>\n

Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

[Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

False<\/span>\u00a0<\/span><\/p>\n

\u202f<\/span>\u00a0<\/span><\/p>\n

It is introduced as early as possible in treatment to mitigate the risks associated with nonadherence.<\/span><\/i>\u00a0<\/span><\/p>\n

\u202f<\/span>\u00a0<\/span><\/p>\n

Question 2<\/span><\/b>\u00a0<\/span><\/h2>\n

0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

G-protein coupled receptors are targets for several psychiatric medications<\/a>. Given what we know about these receptors, what is the ultimate result we will see when one of them is activated in a way that would potentiate an action?<\/span>\u00a0<\/span><\/p>\n

[Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

    \n
  1. Intracellular activation of second messengers<\/span><\/li>\n<\/ol>\n

    \u202f<\/span>\u00a0<\/span><\/p>\n

    You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

    [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

      \n
    1. Protein phosphorylation<\/span><\/li>\n<\/ol>\n

      \u202f<\/span>\u00a0<\/span><\/p>\n

      Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

      [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

        \n
      1. Modification of gene expression<\/span><\/li>\n<\/ol>\n

        \u202f<\/span>\u00a0<\/span><\/p>\n

        A and B are both steps in the activities seen leading up to modification of gene expression.<\/span><\/i>\u00a0<\/span><\/p>\n

        \u202f<\/span>\u00a0<\/span><\/p>\n

        Question 3<\/span><\/b>\u00a0<\/span><\/h2>\n

        0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

        Neurotransmission is unidirectional insofar as chemical and electrical conduction is concerned within the individual neuron. Of the following descriptions, which best characterizes the order of neurotransmitter\/receptor interaction that results in an electrical signal impulse and the release of another neurotransmitter for interaction in the synaptic cleft (signal conduction through a neuron)?<\/span>\u00a0<\/span><\/p>\n

        You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

        Cell body, dendrites, Axon, Axon terminals<\/span>\u00a0<\/span><\/p>\n

        \u202f<\/span>\u00a0<\/span><\/p>\n

        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

        Dendrites, Axon, Cell body, Axon, Axon terminals<\/span>\u00a0<\/span><\/p>\n

        \u202f<\/span>\u00a0<\/span><\/p>\n

        Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

        Dendrites, Cell body, Axon, Axon terminals<\/span>\u00a0<\/span><\/p>\n

        \u202f<\/span>\u00a0<\/span><\/p>\n

        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

        Axon terminals, Axon, Cell body, Dendrites<\/span>\u00a0<\/span><\/p>\n

        \u202f<\/span>\u00a0<\/span><\/p>\n

        All of the other options are mis-sequenced in signal conduction.<\/span><\/i>\u00a0<\/span><\/p>\n

        \u202f<\/span>\u00a0<\/span><\/p>\n

        Question 4<\/span><\/b>\u00a0<\/span><\/h2>\n

        0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

        Neurotransmitters are defined by four essential characteristics. These are:<\/span>\u00a0<\/span><\/p>\n

        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

          \n
        1. Neurotransmitters are synthesized within presynaptic neurons.<\/span><\/li>\n<\/ol>\n

          \u202f<\/span>\u00a0<\/span><\/p>\n

          You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

          [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

            \n
          1. Depolarization of a neuron results in the release of a neurotransmitter, which exerts a multitude of actions on the postsynaptic neuron.<\/span><\/li>\n<\/ol>\n

            \u202f<\/span>\u00a0<\/span><\/p>\n

            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

              \n
            1. Their action on postsynaptic neurons can be replicated by administering a drug that mimics the activity of the endogenous neurotransmitter.<\/span><\/li>\n<\/ol>\n

              \u202f<\/span>\u00a0<\/span><\/p>\n

              [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                \n
              1. Their action in the synaptic cleft is terminated by a specific action.<\/span><\/li>\n<\/ol>\n

                \u202f<\/span>\u00a0<\/span><\/p>\n

                Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                  \n
                1. A, C, and D only<\/span><\/li>\n<\/ol>\n

                  \u202f<\/span>\u00a0<\/span><\/p>\n

                  Answer B should read a \u201cdiscrete\u201d (not multitude) action on the post synaptic neuron.<\/span><\/i>\u00a0<\/span><\/p>\n

                  \u202f<\/span>\u00a0<\/span><\/p>\n

                  Question 5<\/span><\/b>\u00a0<\/span><\/p>\n

                  0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                  Serotonin (5HT) is a neurotransmitter associated with mood, sleep, and psychosis. There are several serotonin receptors all over the human body. A unique aspect of the second generation antipsychotics is their ability to block 5HT2a receptors. What is the effect of this inhibition?<\/span>\u00a0<\/span><\/p>\n

                  Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                    \n
                  1. Stabilizes dopamine concentrations in the CNS<\/span><\/li>\n<\/ol>\n

                    \u202f<\/span>\u00a0<\/span><\/p>\n

                    [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                      \n
                    1. Induces anxiety<\/span><\/li>\n<\/ol>\n

                      \u202f<\/span>\u00a0<\/span><\/p>\n

                      [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                        \n
                      1. Causes hallucinations<\/span><\/li>\n<\/ol>\n

                        \u202f<\/span>\u00a0<\/span><\/p>\n

                        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                          \n
                        1. Reduces platelet function<\/span><\/li>\n<\/ol>\n

                          \u202f<\/span>\u00a0<\/span><\/p>\n

                          B represents antagonism of 5HT1a, C represents a 5HT2a agonist, and D represents what happens when you inhibit SERT.<\/span><\/i>\u00a0<\/span><\/p>\n

                          \u202f<\/span>\u00a0<\/span><\/p>\n

                          Question 6<\/span><\/b>\u00a0<\/span><\/p>\n

                          0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                          Glia cells play a supportive role to the neuron. A few of the functions of the glial cells include providing nutrition, maintaining homeostasis, stabilizing synapses, and myelinating axons. The glial cells are categorized as microglia and macroglia. Of these two cell types, which one plays an active and critical role in glutamatergic neurotransmission by providing a co-agonist required for glutamate receptor function?<\/span>\u00a0<\/span><\/p>\n

                          You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                          [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                          microglial<\/span>\u00a0<\/span><\/p>\n

                          \u202f<\/span>\u00a0<\/span><\/p>\n

                          Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                          [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                          macroglial<\/span>\u00a0<\/span><\/p>\n

                          \u202f<\/span>\u00a0<\/span><\/p>\n

                          Microglial cells are small, phagocytic cells related to peripheral macrophages.<\/span><\/i>\u00a0<\/span><\/p>\n

                          \u202f<\/span>\u00a0<\/span><\/p>\n

                          Question 7<\/span><\/b>\u00a0<\/span><\/p>\n

                          0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                          G-protein coupled receptors are examples of what type of effector pathway?<\/span>\u00a0<\/span><\/p>\n

                          Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                          [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                            \n
                          1. Slow effector pathways<\/span><\/li>\n<\/ol>\n

                            \u202f<\/span>\u00a0<\/span><\/p>\n

                            You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                              \n
                            1. Rapid effector pathways<\/span><\/li>\n<\/ol>\n

                              \u202f<\/span>\u00a0<\/span><\/p>\n

                              [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                \n
                              1. NMDA glutamate receptor pathways<\/span><\/li>\n<\/ol>\n

                                \u202f<\/span>\u00a0<\/span><\/p>\n

                                [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                  \n
                                1. Modulated effector pathways<\/span><\/li>\n<\/ol>\n

                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                  Answer D is fictitious, B represents ion channel receptors, and C is a type of rapid effector pathway.<\/span>\u00a0<\/span><\/p>\n

                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                  Question 8<\/span><\/b>\u00a0<\/span><\/p>\n

                                  0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                  Which neurotransmitter is considered the major excitatory neurotransmitter?<\/span>\u00a0<\/span><\/p>\n

                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                    \n
                                  1. Glycine<\/span><\/li>\n<\/ol>\n

                                    \u202f<\/span>\u00a0<\/span><\/p>\n

                                    [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                      \n
                                    1. GABA<\/span><\/li>\n<\/ol>\n

                                      \u202f<\/span>\u00a0<\/span><\/p>\n

                                      Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                                      [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                        \n
                                      1. Glutamate<\/span><\/li>\n<\/ol>\n

                                        \u202f<\/span>\u00a0<\/span><\/p>\n

                                        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                          \n
                                        1. Serotonin<\/span><\/li>\n<\/ol>\n

                                          \u202f<\/span>\u00a0<\/span><\/p>\n

                                          A and B are inhibitory, and D is involved in mood and sleep.<\/span><\/i>\u00a0<\/span><\/p>\n

                                          \u202f<\/span>\u00a0<\/span><\/p>\n

                                          Question 9<\/span><\/b>\u00a0<\/span><\/p>\n

                                          0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                          When dopamine (subtype 2) receptors are blocked in this pathway (system), it is evident by EPS.<\/span>\u00a0<\/span><\/p>\n

                                          [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                            \n
                                          1. Mesocortical<\/span><\/li>\n<\/ol>\n

                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                              \n
                                            1. Tuberoinfundibular<\/span><\/li>\n<\/ol>\n

                                              \u202f<\/span>\u00a0<\/span><\/p>\n

                                              Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                                              [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                \n
                                              1. Nigrostriatal<\/span><\/li>\n<\/ol>\n

                                                \u202f<\/span>\u00a0<\/span><\/p>\n

                                                [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                  \n
                                                1. Mesolimbic<\/span><\/li>\n<\/ol>\n

                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                  D is associated with positive symptoms in schizophrenia, B is associated with lactation, A is associated with affect.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                  Question 10<\/span><\/b>\u00a0<\/span><\/p>\n

                                                  0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                  1<\/span>Neurons are classified in several different ways. From the following statements, select which ones are true.<\/span>\u00a0<\/span><\/p>\n

                                                    \n
                                                  1. The two structural classifications are projection neurons and local inter-neurons.<\/span>\u00a0<\/span><\/li>\n<\/ol>\n
                                                      \n
                                                    1. Function classifications are made up of two subcategories: excitatory and inhibitory.<\/span>\u00a0<\/span><\/li>\n<\/ol>\n
                                                        \n
                                                      1. Histological classification includes bipolar, unipolar, and multipolar.<\/span>\u00a0<\/span><\/li>\n<\/ol>\n
                                                          \n
                                                        1. Classifications using a combination of structural, functional, and neurotransmitter type provide the most robust and useful description.<\/span>\u00a0<\/span><\/li>\n<\/ol>\n
                                                            \n
                                                          1. Classification by neurotransmitter type alone provides the most useful description.<\/span>\u00a0<\/span><\/li>\n<\/ol>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            I only<\/span>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            III only<\/span>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            I, II, and V only<\/span>\u00a0<\/span><\/p>\n

                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                            You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            I, II, III, IV, and V<\/span>\u00a0<\/span><\/p>\n

                                                            Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            I, III, and IV<\/span>\u00a0<\/span><\/p>\n

                                                            Statement II would need to include modulatory function to be correct, and Statement V does not include structural and functional classification systems.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                            Question 11<\/span><\/b>\u00a0<\/span><\/p>\n

                                                            0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                            The human brain is subcategorized into four major structures. These structures include the cerebral cortex, brainstem, subcortical structures, and the cerebellum. Of these major categories, which one houses the area of the brain that has been found in some neuropathological studies of patients with schizophrenia to be of smaller size?<\/span>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            Cerebral cortex<\/span>\u00a0<\/span><\/p>\n

                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            Brainstem<\/span>\u00a0<\/span><\/p>\n

                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                            Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            Subcortical structures<\/span>\u00a0<\/span><\/p>\n

                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                            Cerebellum<\/span>\u00a0<\/span><\/p>\n

                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                            The area of the brain in question is part of the thalamus, which is located in the subcortical structures. The other options are incorrect, geographically speaking.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                            Question 12<\/span><\/b>\u00a0<\/span><\/p>\n

                                                            0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                            Receptors trigger one of two effector pathways resulting in changes in neuronal activity. These changes will, ultimately, effect gene expression. Which effector pathway is characterized by ion flux through transmitter-activated channels resulting in an altered membrane potential and neuronal activity?<\/span>\u00a0<\/span><\/p>\n

                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                              \n
                                                            1. Slow effector pathways<\/span><\/li>\n<\/ol>\n

                                                              \u202f<\/span>\u00a0<\/span><\/p>\n

                                                              You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                                                              [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                \n
                                                              1. Modulated effector pathways<\/span><\/li>\n<\/ol>\n

                                                                \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                  \n
                                                                1. Rapid effector pathways<\/span><\/li>\n<\/ol>\n

                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                    \n
                                                                  1. NMDA glutamate receptor pathways<\/span><\/li>\n<\/ol>\n

                                                                    \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                    Answer B is fictitious, D is a type of rapid effector pathway, and A represents G-protein coupled receptors.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                    \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                    Question 13<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                    0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                    Upon blocking a Serotonin reuptake pump, what happens in the synaptic cleft and on the post synaptic cell membrane?<\/span>\u00a0<\/span><\/p>\n

                                                                    You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                    [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                      \n
                                                                    1. The result will be an increase in available Serotonin in the synaptic cleft causing the post synaptic cell to increase the number of Serotonin receptors.<\/span><\/li>\n<\/ol>\n

                                                                      \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                      Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                      [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                        \n
                                                                      1. The result will be an increase in the available Serotonin in the synaptic cleft causing the post synaptic neuron to reduce the number of Serotonin receptors.<\/span><\/li>\n<\/ol>\n

                                                                        \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                          \n
                                                                        1. The result will be an increase in Serotonin in the synaptic cleft resulting in an increase in reuptake pumps on the presynaptic neuron.<\/span><\/li>\n<\/ol>\n

                                                                          \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                          [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            \n
                                                                          1. The result will be an increase in Serotonin in the synaptic cleft resulting in a decrease in reuptake pumps on the pre-synaptic neuron.<\/span><\/li>\n<\/ol>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            A, C, and D are misrepresentations of what occurs when you increase Serotonin in the synaptic cleft. There is no effect on the pre-synaptic neuron, and the increases in Serotonin result in a reduction of receptor concentration on the post-synaptic neuron.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Question 14<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            Treatment adherence is affected by several different factors. Clinical factors include mood, anxiety, psychosis, and substance misuse. There are also patient factors such as knowledge, attitude, and beliefs; economic and racial\/ethnic disparities, and clinical encounters. A patient who presents hopeless, with decreased energy, and poor concentration is affected by which factor?<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Substance misuse<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Knowledge deficits<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Attitude ad belief system<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Mood<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            These are signs of an altered mood.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Question 15<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            Of the components of patient-focused interventions to enhance adherence, which component includes the following strategies: adaptive thinking, use of cues, and support?<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Motivation<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Skills<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Logistics<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Education<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Skills include adaptive thinking, problem solving, use of cues, and support.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Question 16<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            Motivation is a component of patient-focused interventions to enhance adherence. Based on the transtheoretical model, readiness to change can fluctuate across five stages. Which stage is represented by the patient who is aware that a problem exists and, while seriously thinking about overcoming it, has not yet committed to a plan of action?<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Preparation<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Action<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Contemplation<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Maintenance<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                            Question 17<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            The synaptic cleft is best characterized by which of the following statements?<\/span>\u00a0<\/span><\/p>\n

                                                                            You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                            [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                              \n
                                                                            1. The synaptic cleft is the space between a single neuron\u2019s dendrites and axon terminals in which intracellular communication occurs through the release of neurotransmitters allowing for signal conduction throughout the central nervous system.<\/span><\/li>\n<\/ol>\n

                                                                              \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                              [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                \n
                                                                              1. The synaptic cleft is the space between the cell body and axon terminals that allows for release of neurotransmitters from the presynaptic neuron for intercellular communication with an adjacent neuron (post synaptic neuron).<\/span><\/li>\n<\/ol>\n

                                                                                \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  \n
                                                                                1. The synaptic cleft is an area where dendrites and axon terminals are within close proximity, allowing for the release of a neurotransmitter from a presynaptic neuron that can interact with receptors on dendritic cells of a post synaptic neuron, which is the main basis for intercellular communication of neurons.<\/span><\/li>\n<\/ol>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Answer A represents a neuron communicating with itself and Answer B states that the synapse is the space between the cell body (not dendrites) and axon terminals.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Question 18<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  If a patient admits to taking his medication every other day (instead of daily, as prescribed), a potential concern would be:<\/span>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Sufficient understanding or acceptance of the illness<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Abuse of the medication<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Expense<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Is the desired effect recognized at a lower daily dose?<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  A represents a patient taking his medication sporadically, B represents a patient taking too much medication, and D represents a patient taking a lower-than-prescribed dose but daily<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Question 19<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  Which of the following consists of all the known major neurotransmitters that are relevant in psychiatry?<\/span>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  glutamate, GABA, dopamine, serotonin, norepinephrine, histamine, steroids, nitric oxide<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Correct!<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  glutamate, GABA, dopamine, norepinephrine, serotonin, acetylcholine, histamine, endogenous opioids, steroids, cannabinoids, nitric oxide<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  glutamate, GABA, dopamine, serotonin, acetylcholine, endogenous opioids, nitric oxide, cannabinoids, steroids<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  glutamate, GABA, dopamine, serotonin, norepinephrine, endogenous opioids, steroids, histamine, nitric oxide<\/span>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  all the other options are missing neurotransmitters considered important in psychiatry<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                                  \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                  Question 20<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  0\u202f\/ 0\u202fpts<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                  A patient arrives in the ED via EMS having a grand mal seizure. The ED physician instructs the RN to give 10 milligrams of Diazepam IV X1 dose STAT. The patient\u2019s seizure breaks within 2 minutes of the Diazepam being administered. The mechanism by which this medication causes rapid resolution of seizure activity is via which receptor type (effector pathway\/receptor subtype)?<\/span>\u00a0<\/span><\/p>\n

                                                                                  [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                    \n
                                                                                  1. Slow effector pathways\/G-protein coupled receptor<\/span><\/li>\n<\/ol>\n

                                                                                    \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                    [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                      \n
                                                                                    1. Slow effector pathway\/ion channel<\/span><\/li>\n<\/ol>\n

                                                                                      \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                      You Answered<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                      [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                        \n
                                                                                      1. Rapid effector pathways\/G-protein coupled receptor<\/span><\/li>\n<\/ol>\n

                                                                                        \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                        Correct Answer<\/span><\/b>\u00a0<\/span><\/p>\n

                                                                                        [Control]\u202f\u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                          \n
                                                                                        1. Rapid effector pathway\/ion channel<\/span><\/li>\n<\/ol>\n

                                                                                          \u202f<\/span>\u00a0<\/span><\/p>\n

                                                                                          Options B and C are mismatched, and Option A shows effects days to weeks after activation.<\/span><\/i>\u00a0<\/span><\/p>\n

                                                                                          \u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

                                                                                          NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW Sample Answer for NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW Included After Question NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS\u00a0 RESOURCES\u00a0 Be sure to review the Learning Resources before completing this activity. Click the weekly resources link to access the resources.\u202f\u00a0 WEEKLY RESOURCES\u00a0 BY DAY 7\u00a0 Complete the […]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-125018","post","type-post","status-publish","format-standard","hentry","category-nursing-papers"],"blocksy_meta":[],"yoast_head":"\nNURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW - Nursing Assignment Crackers<\/title>\n<meta name=\"description\" content=\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW: Introducing adherence in facilitating treatment goals is something that would be necessary in a patient who has previously displayed nonadherence patterns\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW - Nursing Assignment Crackers\" \/>\n<meta property=\"og:description\" content=\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW: Introducing adherence in facilitating treatment goals is something that would be necessary in a patient who has previously displayed nonadherence patterns\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/\" \/>\n<meta property=\"og:site_name\" content=\"Nursing Assignment Crackers\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-01T12:45:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-23T07:41:28+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2-300x87.png\" \/>\n<meta name=\"author\" content=\"Saraphine\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saraphine\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/\"},\"author\":{\"name\":\"Saraphine\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#\/schema\/person\/eb5212513ef8667ef7a4ce51a5333807\"},\"headline\":\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW\",\"datePublished\":\"2024-02-01T12:45:53+00:00\",\"dateModified\":\"2024-03-23T07:41:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/\"},\"wordCount\":1816,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2-300x87.png\",\"articleSection\":[\"Nursing Papers\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/\",\"url\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/\",\"name\":\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW - Nursing Assignment Crackers\",\"isPartOf\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2-300x87.png\",\"datePublished\":\"2024-02-01T12:45:53+00:00\",\"dateModified\":\"2024-03-23T07:41:28+00:00\",\"description\":\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW: Introducing adherence in facilitating treatment goals is something that would be necessary in a patient who has previously displayed nonadherence patterns\",\"breadcrumb\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage\",\"url\":\"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2.png\",\"contentUrl\":\"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2.png\",\"width\":914,\"height\":265,\"caption\":\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/nursingassignmentcrackers.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#website\",\"url\":\"https:\/\/nursingassignmentcrackers.com\/\",\"name\":\"Nursing Assignment Crackers\",\"description\":\"Professional Nursing Assignment Writing Service\",\"publisher\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nursingassignmentcrackers.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#organization\",\"name\":\"Nursing Assignment Crackers\",\"url\":\"https:\/\/nursingassignmentcrackers.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2023\/03\/nurse-2.png\",\"contentUrl\":\"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2023\/03\/nurse-2.png\",\"width\":512,\"height\":512,\"caption\":\"Nursing Assignment Crackers\"},\"image\":{\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#\/schema\/person\/eb5212513ef8667ef7a4ce51a5333807\",\"name\":\"Saraphine\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nursingassignmentcrackers.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3b72d7a762dce500483486826fc831bc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3b72d7a762dce500483486826fc831bc?s=96&d=mm&r=g\",\"caption\":\"Saraphine\"},\"url\":\"https:\/\/nursingassignmentcrackers.com\/author\/saraphine\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW - Nursing Assignment Crackers","description":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW: Introducing adherence in facilitating treatment goals is something that would be necessary in a patient who has previously displayed nonadherence patterns","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/","og_locale":"en_US","og_type":"article","og_title":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW - Nursing Assignment Crackers","og_description":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW: Introducing adherence in facilitating treatment goals is something that would be necessary in a patient who has previously displayed nonadherence patterns","og_url":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/","og_site_name":"Nursing Assignment Crackers","article_published_time":"2024-02-01T12:45:53+00:00","article_modified_time":"2024-03-23T07:41:28+00:00","og_image":[{"url":"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2-300x87.png"}],"author":"Saraphine","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Saraphine","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#article","isPartOf":{"@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/"},"author":{"name":"Saraphine","@id":"https:\/\/nursingassignmentcrackers.com\/#\/schema\/person\/eb5212513ef8667ef7a4ce51a5333807"},"headline":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW","datePublished":"2024-02-01T12:45:53+00:00","dateModified":"2024-03-23T07:41:28+00:00","mainEntityOfPage":{"@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/"},"wordCount":1816,"commentCount":0,"publisher":{"@id":"https:\/\/nursingassignmentcrackers.com\/#organization"},"image":{"@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage"},"thumbnailUrl":"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2-300x87.png","articleSection":["Nursing Papers"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/","url":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/","name":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW - Nursing Assignment Crackers","isPartOf":{"@id":"https:\/\/nursingassignmentcrackers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage"},"image":{"@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage"},"thumbnailUrl":"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2-300x87.png","datePublished":"2024-02-01T12:45:53+00:00","dateModified":"2024-03-23T07:41:28+00:00","description":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW: Introducing adherence in facilitating treatment goals is something that would be necessary in a patient who has previously displayed nonadherence patterns","breadcrumb":{"@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#primaryimage","url":"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2.png","contentUrl":"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-1-2.png","width":914,"height":265,"caption":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW"},{"@type":"BreadcrumbList","@id":"https:\/\/nursingassignmentcrackers.com\/nurs-6630-neurobiology-and-medication-adherence-concepts-new\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nursingassignmentcrackers.com\/"},{"@type":"ListItem","position":2,"name":"NURS 6630 NEUROBIOLOGY AND MEDICATION ADHERENCE CONCEPTS NEW"}]},{"@type":"WebSite","@id":"https:\/\/nursingassignmentcrackers.com\/#website","url":"https:\/\/nursingassignmentcrackers.com\/","name":"Nursing Assignment Crackers","description":"Professional Nursing Assignment Writing Service","publisher":{"@id":"https:\/\/nursingassignmentcrackers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nursingassignmentcrackers.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nursingassignmentcrackers.com\/#organization","name":"Nursing Assignment Crackers","url":"https:\/\/nursingassignmentcrackers.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nursingassignmentcrackers.com\/#\/schema\/logo\/image\/","url":"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2023\/03\/nurse-2.png","contentUrl":"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2023\/03\/nurse-2.png","width":512,"height":512,"caption":"Nursing Assignment Crackers"},"image":{"@id":"https:\/\/nursingassignmentcrackers.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nursingassignmentcrackers.com\/#\/schema\/person\/eb5212513ef8667ef7a4ce51a5333807","name":"Saraphine","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nursingassignmentcrackers.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3b72d7a762dce500483486826fc831bc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3b72d7a762dce500483486826fc831bc?s=96&d=mm&r=g","caption":"Saraphine"},"url":"https:\/\/nursingassignmentcrackers.com\/author\/saraphine\/"}]}},"_links":{"self":[{"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/posts\/125018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/comments?post=125018"}],"version-history":[{"count":9,"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/posts\/125018\/revisions"}],"predecessor-version":[{"id":138595,"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/posts\/125018\/revisions\/138595"}],"wp:attachment":[{"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/media?parent=125018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/categories?post=125018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nursingassignmentcrackers.com\/wp-json\/wp\/v2\/tags?post=125018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}